Fundraising Fox
🦊/Companies
Sign in

CraniUS

Baltimore, US · Founded 2021 · Maryland LLC · 20 employees on LinkedIn

Find your way into CraniUS

78 people in our graph share verified history with the CraniUS team — schools, employers, funds. One of them is your warm intro.

Nimisha Nagarsekarunlockedknows Michael Maglin · together at Colgate-Palmolive (overlapped)
×3knows the team · via Indiana University - Kelley School of Business
×3knows the team · via ConAgra Foods
×4knows the team · via Colgate-Palmolive
knows the team · via CraniUS
Biotech

Founders & leadership

MM
Michael MaglininChief Executive OfficerMichael Maglin is CEO of CraniUS Therapeutics, developing a platform for direct brain access in neurosurgical applications. His background centers on corporate strategy, partnerships, and capital formation.
CG
Chad GordonNamed on SEC filing
HB
Henry BremNamed on SEC filing
DI
Deborah I WeidmanNamed on SEC filing
HB
H Brett FriedmanNamed on SEC filing

Board

JS
Joshua ScheinkerBoard director
BM
Brian MoranBoard director
ES
Elliot StoneBoard director
SK
Steven KlaskoBoard director
BF
Brett FriedmanBoard director
OB
Oray Boston, Jr.Board director
SW
Sharon WolfingtonBoard director

Reported raises · per SEC filings

Form D private placements

$38.4M disclosed across 2 rounds · 2021–2026

▶$19MraisedMar 2026 · 49 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael MaglinExecutive Officer
  • Elliot StoneDirector
  • Steven KlaskoDirector
  • Brett FriedmanDirector
  • Oray Boston, Jr.Director
  • Joshua ScheinkerDirector
  • Sharon WolfingtonDirector
  • Chad GordonDirector
  • Brian MoranDirector
Offering amount
$20M
Amount sold
$19M
Minimum investment
$50K
First sale
Feb 2026
Incorporated
Limited Liability Company, Maryland, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.4MraisedMay 2022 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Elliot StoneDirector
  • Brian MoranDirector
  • Henry BremDirector
  • Sharon WolfingtonDirector
  • Michael J MaglinExecutive Officer, Promoter
  • Chad GordonExecutive Officer, Director, Promoter
  • Joshua ScheinkerDirector
  • Deborah I WeidmanExecutive Officer
  • H Brett FriedmanDirector
Offering amount
$20M
Amount sold
$19.4M
Minimum investment
$500K
First sale
Aug 2021
Incorporated
Limited Liability Company, Maryland, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

CraniUS Wins Up to $4 Million NIH Funding to Advance Skull-Embedded NeuroPASS Platform - TipRanks.comtipranks.com · Jun 2026NIH Awards Up to $4 Million to CraniUS Therapeutics to Advance Skull-Embedded Platform Designed to Bypass the Blood-Brain Barrierprnewswire.com · Jun 2026Hopkins spinout CraniUS raises $20M to develop brain implant - Baltimore Business Journalbizjournals.com · Feb 2026StartUp Health (@startuphealth) on Xx.com · Feb 2026CraniUS Therapeutics Closes $20 Million Series B Round to Advance NeuroPASS™ Platform Towards Future Commercializationprnewswire.com · Jan 2026CraniUS Therapeutics Raises $20M in Series B Fundingfinsmes.com · Jan 2026

Frequently asked questions

How much funding has CraniUS raised?
CraniUS has disclosed $38.4M raised across 2 rounds.
Where is CraniUS headquartered?
CraniUS is headquartered in Baltimore, US.